Ciprofloxacin intravenous Infusion BP 200mg/100ml belongs to the class of antibiotic medication known as fluoroquinolones used to treat bacterial infections such as respiratory tract infections, ear, sinus infections, urinary tract infections, genital tract infections, gastrointestinal tract infections, intra-abdominal infections, skin & soft tissue infections, and bone & joint infections. Ciprofloxacin intravenous Infusion BP 200mg/100ml is also used to treat inhalational anthrax post-exposure and as empirical therapy for febrile neutropenic patients.

Ciprofloxacin intravenous Infusion BP 200mg/100ml is antibacterial in nature and kills the bacteria that trigger various infections. Ciprofloxacin intravenous Infusion BP 200mg/100ml contains Ciprofloxacin which inhibits the division and repair of bacterial cells, thereby killing the bacteria. As a result, it treats a wide range of bacterial infections.

Key Features of Ciprofloxacin Intravenous Infusion BP 200mg/100ml

• Broad-spectrum activity: Effective against a wide range of Gram-negative and some Gram-positive bacteria.
• Rapid absorption: High bioavailability, especially when administered intravenously, ensures fast and effective treatment.
• Well-tolerated: Generally well-tolerated with a lower risk of significant adverse reactions.
• Alternative to oral therapy: Ideal for patients who are unable to take oral antibiotics due to gastrointestinal issues or severe infections.

Indications for Ciprofloxacin Intravenous Infusion BP 200mg/100ml

• Lower respiratory tract infections (e.g., pneumonia, COPD exacerbations)
• Bronchopulmonary infections (e.g., cystic fibrosis, bronchiectasis)
• Chronic suppurative otitis media
• Acute sinusitis, pyelonephritis, bacterial prostatitis
• Genital tract infections (e.g., epididymo-orchitis, pelvic inflammatory disease)
• Gastrointestinal infections (e.g., traveler’s diarrhea)
• Intra-abdominal, skin, soft tissue, bone, and joint infections
• Malignant otitis externa, inhalational anthrax (post-exposure and curative)
• Neutropenic fever

Children & Adolescents:

• Bronchopulmonary infections (Pseudomonas aeruginosa in cystic fibrosis)
• Complicated urinary tract infections, acute pyelonephritis
• Inhalational anthrax (post-exposure and curative)
• Severe infections when necessary

Ciprofloxacin should be used with caution based on resistance data.

Dosage And Administration:

• Adult Dosage: The usual dose for intravenous administration in adults ranges from 200 mg to 400 mg every 12 hours, depending on the type and severity of infection. The dose should be infused over 60 minutes to reduce the risk of adverse effects.
• Duration: Treatment duration is typically 7 to 14 days, based on the severity and type of infection.
• Administration: Infuse the drug intravenously over 60 minutes. It can be diluted with appropriate solutions (such as saline or glucose) before infusion.
• Renal Adjustment: Dose adjustments may be required in patients with renal impairment.

Note: Consult your healthcare provider

Precautions:

The use of ciprofloxacin should be avoided in patients who have experienced serious adverse reactions in the past when using quinolone or fluoroquinolone-containing products. Treatment of these patients with ciprofloxacin should only be initiated in the absence of alternative treatment options and after careful benefit/risk assessment.

Note: Consult your healthcare provider

Side Effects:

Decreased appetite, hyperactivity/psychomotor agitation.

NOTE: Most side effects are temporary and go away on their own, but see your doctor if they last or cause concern.

How to store Ciprofloxacin Intravenous Infusion BP 200mg/100ml?

• Store at a temperature not exceeding, 30°C.
• Protect from light & moisture.

Why Choose Ciprofloxacin Intravenous Infusion BP 200mg/100ml From Regen Global Pharma?

• Effective Broad-Spectrum Antibiotic: Ciprofloxacin is a well-established fluoroquinolone antibiotic known for its efficacy in treating a wide range of bacterial infections, including respiratory, urinary tract, and skin infections, among others.
• IV Formulation for Severe Infections: The intravenous (IV) formulation allows for rapid administration and absorption, making it ideal for patients who cannot take oral medication or for those with severe infections that require immediate treatment.
• High-Quality Standards: As a BP (British Pharmacopoeia) product, it adheres to high manufacturing standards, ensuring quality, consistency, and safety. This can be a key consideration for healthcare providers when selecting medications.
• Trusted Brand: Regen Global Pharma is recognized in the pharmaceutical industry for producing high-quality products, which may offer healthcare professionals confidence in its safety and efficacy.
• Convenient Dosage: The 200mg/100mL concentration is convenient for dosing in clinical settings, especially for patients with moderate to severe infections that require a standardized infusion.
• Cost-Effectiveness: If Regen Global Pharma offers competitive pricing for their products, this could be a cost-effective alternative without compromising on quality or efficacy, which is crucial for hospitals and healthcare providers managing budgets.

Always consult a healthcare provider for the most appropriate choice based on the specific medical needs of the patient.

Disclaimer: The information provided on this website is for informational purposes and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it. 

Partner with us as we pave the way for a healthier world.

ABOUT REGEN GLOBAL PHARMA PVT. LTD.:

As one of India’s leading exporters and pharmaceutical manufacturing company in Gujarat, ReGen Global Pharma Pvt. Ltd is committed to global distribution of crucial molecules that advance healthcare solutions worldwide. We have our presence in Togo, Mali, Cameroon, Gambia, Sierra Leone, Burkina Faso, Burundi, Benin Republic, Nigeria, Ghana, Niger, Chad, as well as the Caribbean Island of Guyana, Turkmenistan, and Uzbekistan in Central Asia. 

With over 500+ products, ReGen’s unwavering focus on quality pharma products, innovation, and sustainability drives our mission to improve lives through accessible and effective pharmaceuticals.

With a dedicated team of experts, state-of-the-art facilities, and strategic partnerships, we strive to make a positive impact on global health.
 

WHY REGEN GLOBAL PHARMA PVT. LTD.:

At ReGen Global Pharma Pvt. Ltd., we’re always eager to connect with our partners, clients, and the broader community. Whether you have questions about our products, need assistance with pharmaceutical solutions, or want to explore collaboration opportunities, our dedicated team is ready to assist you.

Reach out to us via email at info@regenglobal.life, or get in touch at+91 7878 233 388, during business hours. We prioritize prompt and clear communication, ensuring that your inquiries are handled with the utmost care and professionalism. Let’s work together towards a healthier future.

Click here to know more about us, our new launches, our bestsellers, top molecules.